N4-(1H-indazol-6-yl)-5-methyl-N2-(4-piperazin-1-ylphenyl)pyrimidine-2,4-diamine

ID: ALA5177453

Chembl Id: CHEMBL5177453

PubChem CID: 156704705

Max Phase: Preclinical

Molecular Formula: C22H24N8

Molecular Weight: 400.49

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cnc(Nc2ccc(N3CCNCC3)cc2)nc1Nc1ccc2cn[nH]c2c1

Standard InChI:  InChI=1S/C22H24N8/c1-15-13-24-22(27-17-4-6-19(7-5-17)30-10-8-23-9-11-30)28-21(15)26-18-3-2-16-14-25-29-20(16)12-18/h2-7,12-14,23H,8-11H2,1H3,(H,25,29)(H2,24,26,27,28)

Standard InChI Key:  ZECGOWQXESMVBI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5177453

    ---

Associated Targets(Human)

PDGFRA Tclin Platelet-derived growth factor receptor alpha (5682 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 400.49Molecular Weight (Monoisotopic): 400.2124AlogP: 3.56#Rotatable Bonds: 5
Polar Surface Area: 93.79Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.84CX Basic pKa: 8.91CX LogP: 3.61CX LogD: 2.09
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.41Np Likeness Score: -1.61

References

1. Chen X, Liu L, Liu P, Chen Y, Lin D, Yan H, Yan Q, Wang Y, Qiu Y, Fang B, Huang H, Qian J, Zhao Y, Du Z, Zhang Q, Li X, Zheng X, Liu Z..  (2022)  Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma.,  65  (7.0): [PMID:35239349] [10.1021/acs.jmedchem.1c01732]

Source